Pancreatic Cancer Research

ResearcherUniversity of TorontoActive in the last 2 years

Aaron Richard Hansen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2363-8707; OpenAlex author ID A5022267545. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer. Last author DOI 10.1016/j.clcc.2024.05.002↗
  2. A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1111/cts.12802↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lillian Siu · 2 shared papers, 2020–2024 · strength 0.25
  2. María Vila-Casadesús · 1 shared paper, 2024 · strength 0.16
  3. Alberto Hernando‐Calvo · 1 shared paper, 2024 · strength 0.16
  4. Benjamin Haibe‐Kains · 1 shared paper, 2024 · strength 0.16
  5. Ana P. Vivancos · 1 shared paper, 2024 · strength 0.16
  6. Philippe Lucien Bedard · 1 shared paper, 2024 · strength 0.16
  7. Barry D. Nelkin · 1 shared paper, 2020 · strength 0.09
  8. Noelle K. LoConte · 1 shared paper, 2020 · strength 0.09
  9. Adrian Gerard Murphy · 1 shared paper, 2020 · strength 0.09
  10. Nilofer Saba Azad · 1 shared paper, 2020 · strength 0.09
  11. Anirban Maitra · 1 shared paper, 2020 · strength 0.09
  12. Colin D. Weekes · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.